<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-AP22MDIY</identifier><date>2022</date><creator>Gornik-Kramberger, Kristina</creator><creator>Hladnik, Gaja</creator><creator>Marš, Tomaž</creator><creator>Pirkmajer, Sergej</creator><creator>Potrč, Stojan</creator><relation>documents/doc/A/URN_NBN_SI_doc-AP22MDIY_001.pdf</relation><relation>documents/doc/A/URN_NBN_SI_doc-AP22MDIY_001.txt</relation><format format_type="issue">1</format><format format_type="volume">4</format><format format_type="type">article</format><format format_type="extent">str. 47-50</format><identifier identifier_type="COBISSID">138069251</identifier><identifier identifier_type="ISSN">2591-2275</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-AP22MDIY</identifier><language>eng</language><publisher>Združenje za endoskopsko kirurgijo Slovenije</publisher><source>Surgery and surgical endoscopy</source><rights>InC</rights><subject language_type_id="slv">aktivacija</subject><subject language_type_id="slv">debelost</subject><subject language_type_id="slv">leptin</subject><subject language_type_id="slv">rak (medicina)</subject><subject language_type_id="slv">želodec</subject><title>Leptin is involved in activation of JAK-STAT3, PI3K-Akt, and SHP2-ERK1//2 signaling in gastric cancer in the upper third of the stomach</title><title>a study protocol</title></Record>